Source link : https://newshealth.biz/health-news/novel-biologic-performs-well-in-igg4-related-disease/
LONDON — An investigational monoclonal antibody drug for immunoglobulin (Ig)G4-related disease called obexelimab substantially outperformed placebo in the phase III INDIGO trial, researchers reported, positioning it to take on the only drug now specifically approved for the condition. Time to first disease flare after starting therapy was more than halved with obexelimab, and twice as […]
The post Novel Biologic Performs Well in IgG4-Related Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-02 23:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8